/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

M

Masahiro Nagai

Ehime University Hospital(JP)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

388

Papers

6.2K

Citations

36

h-index

121

i10-index

Masahiro Nagai is an academic researcher from Ehime University Hospital. The author has contributed to research in topics: Parkinson's Disease Mechanisms and Treatments & T-cell and Retrovirus Studies & Neurological disorders and treatments. The author has an h-index of 36, co-authored 330 publications.

ORCID: 0000-0001-5473-4913

Research Topics

Parkinson's Disease Mechanisms and Treatments T-cell and Retrovirus Studies Neurological disorders and treatments Animal Disease Management and Epidemiology Natural product bioactivities and synthesis

Papers by this author

works

Jejunal Infusion of Levodopa–Carbidopa Intestinal Gel Versus Oral Administration of Levodopa–Carbidopa Tablets in Japanese Subjects with Advanced Parkinson’s Disease: Pharmacokinetics and Pilot Efficacy and Safety

2015 · Clinical Pharmacokinetics · 24 citations

https://doi.org/10.1007/s40262-015-0265-3

Ahmed A. Othman Krai Chatamra Mohamed‐Eslam F. Mohamed Sandeep Dutta

<i>PICALM</i> mRNA Expression in the Blood of Patients with Neurodegenerative Diseases and Geriatric Depression

2020 · Journal of Alzheimer s Disease · 23 citations

https://doi.org/10.3233/jad-201046

Hiroshi Kumon Yuta Yoshino Yu Funahashi Hiroaki Mori

Long-term, open-label, phase 3 study of rasagiline in Japanese patients with early Parkinson’s disease

2019 · Journal of Neural Transmission · 17 citations

https://doi.org/10.1007/s00702-018-1964-3

Nobutaka Hattori Atsushi Takeda Shin‐ichi Takeda Akira Nishimura

Modafinil alleviates levodopa-induced excessive nighttime sleepiness and restores monoaminergic systems in a nocturnal animal model of Parkinson's disease

2018 · Journal of Pharmacological Sciences · 15 citations

https://doi.org/10.1016/j.jphs.2018.03.005

Rina Ando Mohammed E. Choudhury Yuki Yamanishi Win Thiri Kyaw

Pharmacokinetics and safety/efficacy of levodopa pro-drug ONO-2160/carbidopa for Parkinson's disease

2018 · eNeurologicalSci · 15 citations

https://doi.org/10.1016/j.ensci.2018.09.003

Masahiro Nomoto Masahiro Nagai Noriko Nishikawa Rina Ando

Multicenter, randomized, double-blind, placebo-controlled phase 3 study of mogamulizumab with open-label extension study in a minimum number of patients with human T-cell leukemia virus type-1-associated myelopathy

2024 · Journal of Neurology · 11 citations

https://doi.org/10.1007/s00415-024-12239-x

Tomoo Sato Masahiro Nagai Osamu Watanabe Tatsuro Misu

Research topics

topics

Parkinson's Disease Mechanisms and Treatments

T-cell and Retrovirus Studies

Neurological disorders and treatments

Animal Disease Management and Epidemiology

Natural product bioactivities and synthesis

Chat about Author

Papers

Chat

Click to start Chat